These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia.
    Author: Kim JH, Lee EJ, Kwon OH.
    Journal: Clin Biochem; 1997 Feb; 30(1):47-52. PubMed ID: 9056109.
    Abstract:
    OBJECTIVES: We investigated the possible effect of apolipoprotein E (apo E) polymorphism on hypertriglyceridemia in type II diabetes mellitus (DM) patients by both apo E genotyping and phenotyping methods. DESIGN AND METHODS: Eighty Korean type II DM patients were evaluated. Restriction isotyping after DNA amplification was used for apo E genotyping. The isoelectric focusing of neuraminidase-treated sera followed by immunoblotting was used for apo E phenotyping. RESULTS: The concordant rate between apo E genotyping and phenotyping was 96.3%. Apo E genotype frequencies for all 77 concordant cases were as follows: 72.7% for epsilon 3/3; 16.9% for epsilon 3/4; 7.8% for epsilon 2/3; 1.3% for epsilon 2/4, 1.3% for epsilon 4/4; and 0% for epsilon 2/2. There were no significant differences in apo E genotype frequencies between hypertriglyceridemic (n = 42) and normotriglyceridemic (n = 35) groups. CONCLUSIONS: Our findings could not support the association between apo E polymorphism and hypertriglyceridemia among type II DM patients.
    [Abstract] [Full Text] [Related] [New Search]